MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, LGNZZ has $1,560,637K in assets. $543,425K in debts. $174,927K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
2222.53%
Quick Ratio
2198.16%
Cash Ratio
467.13%
Debt to Asset Ratio
34.82%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Intangible assets, net
    • Long-term portion of financial r...
    • Others
Liabilities Breakdown
    • Retained earnings
    • 2030 convertible senior notes, n...
    • Additional paid-in capital
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
174,927
Short-term investments
558,594
Accounts receivable, net
59,601
Inventory
9,126
Short-term portion of financial royalty assets
22,792
Income taxes receivable
1,446
Other current assets
5,785
Total current assets
832,271
Intangible assets, net
225,438
Goodwill
101,541
Long-term portion of financial royalty assets, net
196,877
Noncurrent derivative assets
15,632
Equity method investments
46,500
Other investments
121,451
Deferred income taxes, net
8,345
Property and equipment, net
3,571
Right-of-use assets
7,223
Other
1,788
Other assets
12,582
Total assets
1,560,637
Accounts payable
3,238
Accrued liabilities
31,453
Income tax payable
1,239
Current contingent liabilities
287
Current operating lease liabilities
1,095
Other current liabilities
135
Total current liabilities
37,447
Long-term deferred revenue
0
Long-term contingent liabilities
2,934
Long-term operating lease liabilities
4,204
2030 convertible senior notes, net
446,192
Deferred income taxes, net
36,019
Other long-term liabilities
16,629
Total liabilities
543,425
Common stock, 0.001 par value 60,000 shares authorized 19,774 and 19,106 shares issued and outstanding at december31, 2025 and 2024, respectively
20
Additional paid-in capital
400,649
Accumulated other comprehensive income (loss)
8,455
Retained earnings
608,088
Total stockholders equity
1,017,212
Total liabilities and stockholders equity
1,560,637
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$558,594K Cash and cashequivalents$174,927K Accounts receivable, net$59,601K Short-term portion offinancial royalty assets$22,792K Inventory$9,126K Other current assets$5,785K Income taxesreceivable$1,446K Right-of-use assets$7,223K Property and equipment,net$3,571K Other$1,788K Total current assets$832,271K Intangible assets, net$225,438K Long-term portion offinancial royalty assets,...$196,877K Other investments$121,451K Goodwill$101,541K Equity methodinvestments$46,500K Noncurrent derivativeassets$15,632K Other assets$12,582K Deferred income taxes,net$8,345K Total assets$1,560,637K Total liabilities andstockholders equity$1,560,637K Total stockholdersequity$1,017,212K Total liabilities$543,425K Retained earnings$608,088K Additional paid-in capital$400,649K Accumulated othercomprehensive income (loss)$8,455K Common stock, 0.001 parvalue 60,000 shares...$20K 2030 convertiblesenior notes, net$446,192K Total currentliabilities$37,447K Deferred income taxes,net$36,019K Other long-termliabilities$16,629K Long-term operating leaseliabilities$4,204K Long-term contingentliabilities$2,934K Accrued liabilities$31,453K Accounts payable$3,238K Income tax payable$1,239K Current operating leaseliabilities$1,095K Current contingentliabilities$287K Other currentliabilities$135K

LIGAND PHARMACEUTICALS INC (LGNZZ)

LIGAND PHARMACEUTICALS INC (LGNZZ)